Last reviewed · How we verify

Salonsip plaster — Competitive Intelligence Brief

Salonsip plaster (Salonsip plaster) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical analgesic/anti-inflammatory plaster. Area: Pain Management / Musculoskeletal Disorders.

phase 3 Topical analgesic/anti-inflammatory plaster Pain Management / Musculoskeletal Disorders Small molecule Live · refreshed every 30 min

Target snapshot

Salonsip plaster (Salonsip plaster) — Hisamitsu Farmaceutica do Brasil Ltda. Salonsip is a transdermal plaster that delivers salicylic acid and other active ingredients through the skin to provide localized pain relief and anti-inflammatory effects.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Salonsip plaster TARGET Salonsip plaster Hisamitsu Farmaceutica do Brasil Ltda phase 3 Topical analgesic/anti-inflammatory plaster

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical analgesic/anti-inflammatory plaster class)

  1. Hisamitsu Farmaceutica do Brasil Ltda · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Salonsip plaster — Competitive Intelligence Brief. https://druglandscape.com/ci/salonsip-plaster. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: